BUDGETS
ACCESS TO YOUR TESTS
MY RESULTS
PROFESSIONAL ACCESS
Description
SAMPLE TYPE: Serum
RESULTS: 4 DAYS
Delivery of results from receipt of sample
- Detects hidden atherosclerotic risk: ApoB quantifies the actual number of atherogenic particles, identifying patients with apparently normal LDL-C but elevated risk.
- Identifies relevant genetic risk: Lp(a) allows for reclassification of cardiovascular risk, intensification of therapeutic targets, and guidance of specific treatments and family screening.
- Evaluates vascular inflammation: hsCRP detects residual inflammatory risk, key to preventing events even with controlled lipids.
- Optimizes treatment and monitoring: facilitates more precise targets (ApoB, non-HDL), adjusts therapeutic intensity, and allows monitoring of the actual reduction in cardiovascular risk.
- Apolipoprotein B [APO B]
- Apolipoprotein A1 [APO A1]
- Lipoprotein (a) Lp(a)
- Total Cholesterol
- HDL cholesterol
- Triglycerides
- LDL Cholesterol
- CRP PCR-us hsCRP
- ApoB/ApoA1 Ratio
- Atherogenic Risk (TG/HDL, n-HDL)
For more information, contact the Teletest administration department at 932 12 33 45 or through the following form
